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Introduction
            Recently introduced pacemaker leads float freely within the veins and myocardium. Later 
on, fibrous encapsulation of the lead develops 1. These adhesions not only occur at the lead tip 
but are commonly found anywhere along the whole length of the lead at sites where the lead is in 
contact with the vein or the myocardium 1-4. These adhesions hamper lead removal as tight scar 
tissue can withhold the leads during traction. This not only occurs at the level of the flings and 
tines of passive fixation leads but at any level of the lead body, especially at sites of unequal 
diameter for example electrodes and defibrillator coils. Further the lead tip is often larger than 
the lead body due to the fixation mechanism and adhering scar tissue and can become impacted 
on   withdrawal   in   the   narrow   canal   provided   by   the   fibrous   envelope.                  
            Force applied to leads is limited by the tensile strength of the insulation and conductor 
coils of the leads. They may severe with forceful traction, and denuded indwelling lead 
fragments   have  a  higher  incidence  of  thrombo-fibrotic  complications  and  may  maintain 
infection5-8. Force is also limited by the impact of traction on the veins and myocardium. 
Unopposed traction can lead to invagination of the myocardium, myocardial rupture, arrhythmia, 
hypotension or avulsion of a tricuspid valve leaflet9-13.                                           
            Therefore, additional tools have been developed to assist in freeing the lead body from 
the adhesions as well as the lead tip from the myocardium, to prevent laceration of the 
myocardium and to provide enough room for the lead to be withdrawn whilst preventing 
disintegration of the lead. We describe the technical aspects of current endovascular techniques, 
the results, the complications and shortly discuss the indications.                                   
Technique of extraction.                                                                                         
Traction
            Direct traction without additional tools is the most basic technique for lead extraction. 
Rosenheck et al. added 5- 10 times rotation of the lead with simultaneous gentle traction14. 
Another modification consists of prolonged graded traction15-17. For this purpose, increasing 
weights are connected to the proximal end of the lead. They are guided over a pulley mounted on 
the bed of the patient or, to keep the patient ambulatory, fixed under tension to the skin using 
rubber  bands  and  adhesive  tape.                                                                            
Locking   stylets                                                                                    
            To avoid disintegration of the lead during traction, a locking stylet is introduced into the 
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central lumen of the lead. It consists of a straight non-expandable wire that can be locked into the 
coil close to the tip of the lead. The force exerted via a locking stylet is almost directly applied at 
the tip, bypassing most of the conductor and the insulation. Locking mechanisms differ between 
manufacturers and recently introduced devices can be unlocked and repositioned if necessary.
            There are limitations to the use of a locking stylet. If the conductor is broken or distorted 
it is not possible to introduce the stylet. Excessive force can dislocate the stylet or the distal 
conductor coil can still unwind or even disconnect from the electrode. Similar as with direct 
traction it does not provide a solution for either the risk of invagination of the myocardium or for 
removing   the   bulbous   tip   through   the   fibrous   sheaths   along   the   body   of   the   lead. 
Conventional intravascular counter traction                                               
            To overcome the limitations of a locking stylet, two telescoping synthetic sheaths can be 
alternately advanced over the lead. The fibrous bindings within the veins or myocardium can be 
mechanically disrupted, and at the same time enough room is created to remove the lead 18,19. It 
is necessary to use a locking stylet: the leads are often to fragile to withstand the traction 
necessary to align the sheaths with the lead and to counter the forces applied to advance the 
sheath. Once the distal electrode is reached counter traction is applied: the larger bore outer 
sheath is positioned and held against the myocardium to prevent its inversion during traction on 
the locking stylet. The force is thus concentrated at a small area of the scar tissue without gross 
displacement of the myocardium.                                                                                 
Although   counter   traction   prevents   invagination   of   the   myocardium,   perforation   of   the 
myocardium is still possible. The lead tip may have been incorporated into the myocardium, 
inevitably leading to a perforation after dislocation of the tip. Further, the possibility of 
increasing the force using counter-traction can lacerate the myocardium especially in the thin-
walled atrium20,21.                                                                                                   
Laser   assisted   extraction                                                                                
            A laser sheath replaces the inner sheath with laser assisted lead extraction22-25. The laser 
sheath consists of optic fibers spirally warped between the inner and outer tubing of the sheath 
(Figure 1). At the tip of the device the fibers are arranged in a ring from which the pulsed laser 
light is emitted to ablate the tissue (Figure 2). Lasing energy is delivered with a 308 nm XeCl 
excimer laser (Spectranetics CVX-300) which emits pulsed light at a maximum fluence of 60 
mJ/mm2 and a 40 - 80 Hz repetition rate. The ablation mechanism combines photochemical 
destruction of cellular structures with explosive photo-thermal vaporization of cellular water, 
which creates transient micro-bubbles to mechanically disrupt the tissue. As the penetration 
depth of 308 nm light in vascular tissue is approximately 100 micron, it is completely absorbed 
in the tissue immediately in front of the tip. This results in an ablation depth, depending on the 
applied force, between 2 and 15 microns per pulse in the experimental setting26. Force exerted 
on the sheath increases the mechanical effect of the micro-bubbles entrapped beneath the tip of 
the device in creating microscopic tears. The ablation results in a shearing of the fibrous scar, 
often leaving a rim around the lead. It has to be understood that the blunt tip of the laser sheath is 
not suited for direct mechanical disruption of the fibrous scar and that applying more force than 
necessary to assure good contact with the tissue does not improve efficacy but increases the risk 
of complications.                                                                                                                     . 
           As with conventional sheaths the outer sheath helps to align the laser sheath with the lead 
and facilitates its handling by reducing friction with the surrounding tissue. Lasing can only be 
applied until the distal electrode to prevent myocardial perforation. Therefore, counter-traction is 
still necessary to dislocate the tip. The synthetic outer sheath is used for counter-traction as the 
inner diameter of the laser sheath is often too small to accommodate the lead tip and its 
attachments. It has to be noted that the laser has no effect on the insulation of the leads. To 
accommodate for different sizes of leads 12, 14 and 16 F sheaths are available.
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Figure 1: The Spectranetics laser sheath  Figure 2: Tip of the laser sheath with 
the   optical   fibers   circumferentially 
arranged around the tip
Electrosurgical   sheaths                                                                                
             An emerging new technique is the bipolar electrosurgical dissection sheath. Two 
electrodes are mounted on the beveled tip of a synthetic sheath (similar to a conventional sheath) 
and radiofrequency energy is applied between them providing bipolar point dissection of scar 
tissue. Interestingly, directional dissection is theoretically possible by rotating the sheath to 
orientate the bipole. Similar as with a laser sheath, counter traction is used to dislocate the tip.
Transfemoral   approach                                                                        
            All previous techniques used a superior approach from the lead insertion site, but with 
the transfemoral approach a long 16 F sheath is introduced via the femoral vein towards the right 
atrium. Then, a retriever is inserted through the sheath to grab and secure the lead as close to the 
tip as possible (Fig.3). The lead (with the connector cut off) is pulled inferiorly by the retriever 
whilst the outer sheath is advanced over the doubled up lead (Fig.4). The proximal part of the 
lead is pulled down through the fibrous envelope; the distal binding sites are disrupted by the 
advancing outer sheath. When the sheath reaches the distal electrode, counter traction is again 
applied. In comparison to the superior approach, the isodiametric lead body is often readily 
pulled down from the binding sites not hampered by a bulbous tip. Although no locking stylet is 
used to reinforce the lead, the shorter distance from the retriever to the tip decreases the change 
of elongating the lead. The technique is especially useful to remove severed and indwelling leads 
or as back-up after failed superior attempts 22. Bongiorni et al. first pulled the proximal end of 
the lead down from the femoral vein, then retrieved the lead via the internal jugular vein. 
Fig. 3. Retriever mechanism of Needle's 
eye retriever (Cook Inc., In). The lead is 
first grabbed by the curved hook en 
secured by advancing the loop through 
the curved hook
Fig. 4. After securing the lead with the 
retriever it is pulled down whilst the 
outer   sheath   is   advanced   over   the 
doubled up lead.
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Results
          The results and complications of different extraction techniques are summarized in Table 
1. Although traction and graded traction for lead extraction have been reported on for more than 
30 years only Rosenheck et al. recently reported results with the use of rotational forces14. 
Applied on 113 leads in 81 patients this method resulted in complete removal in 86 % of the 
leads. In 6 % leads dislocated from the myocardium but proximal adhesions impeded removal of 
the   lead.   In   8   %,   traction   was   unsuccessful.                                                        
            Locking stylets have been reported as a stand-alone extraction tool. Alt et al. reported 
their experience with the VascoExtor stylet (VascoMed GmbH, Weil am Rhein, Germany) in 
150 leads in 105 patients, (110 ventricular leads, 40 atrial; passive fixation with tines in 109 
leads). Complete removal was possible in 81 % of cases, partial removal in 12 %. Manolis et al. 
reported success with the same device in 24 out of 25 leads: in 81 % with the sole use of a stylet, 
in 19 % with additional tools27. Results of counter traction technique using conventional sheaths 
includes also the use of a femoral approach and are reported in the U.S. Lead Extraction 
Database 20. Complete removal was achieved in 86.8 % and partial removal in 7.5 % of 2,195 
leads. In a paper describing their experience with lead extraction between 1994 and 1996, Byrd 
et al. reported complete removal in 93 % and partial removal in 5 % of 3540 leads in 2338 
patients21.                                                                        
            Klug et al. reported results of a femoral approach alone with a Needle's Eye snare in 70 
leads out of 82 leads extracted in 39 patients 28. Eighty-seven percent of leads were successfully 
extracted, 4 % incomplete and 9 % failures.                                                           
            In a European multi-center study laser sheath extraction was attempted of 179 leads in 
149 patients (104 atrial, 57 ventricular, one superior vena cava ICD and 17 ventricular ICD 
leads) 29. Complete extraction was achieved in 89.5% of the leads, 6% were partially extracted 
and 4.5% of the extractions failed. Three out of the 8 failures were completely removed by a 
femoral non-laser approach, 1 with an alternative superior approach and 1 with thoracotomy. 
            In a United States registry of 1684 patients undergoing laser sheath extraction of 2561 
leads, complete success was achieved in 90 % and partial success in 3 % of leads 30. In the Excl 
trial of lead extraction of 287 leads in 166 patients with bipolar electrosurgical sheaths 96% of 
leads was completely removed ,4 % partially removed and only one lead not removed (laser 
sheath as an adjunct was used in 2 % of cases) 31.                                                     
            There is only one trial comparing extraction techniques in a randomized fashion. In the 
Plexus trial 465 leads were randomized between the laser sheath and conventional sheaths (all 
investigators had experience with the conventional technique) 23. Crossover from non-laser to 
laser was allowed in case of failure of the non-laser approach. Initial attempts at extraction were 
successful in 94% of leads with the laser sheath against 64 % of leads with the conventional 
sheaths. However, there was a 33.5 % crossover from conventional techniques to laser. This 
reflected the  greater predictability of  laser  assisted  lead  extraction as  perceived by  the 
investigators, hence the low threshold for abandoning conventional sheaths if success was not 
swiftly obtained. If no crossover was allowed one should have expected a success rate in the 
non-laser group comparable to the published data on conventional extraction 20,21.              
             Successful lead extraction is especially dependent on implant duration: Byrd et al. 
reported that the risk of failed or partial doubled for every 3 year of implant  21. Further, 
extraction is more likely to be successful with increasing physician's experience, atrial leads and 
infected leads 32.
Complications
            Using only traction, Rosenheck et al. reported only 1 out of 89 patients with a small 
pericardial effusion 14. With conventional sheaths or a femoral workstation, major complications 
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occurred in the U.S. Lead Extraction Database in 2.5 % of the 1,299 patients (hemopericardium 
or tamponade 1.2 %, hemothorax 0.5 % and pulmonary embolism 0.2 %, death 0.6 %) and in the 
experience of Byrd et al. in 1.4 % of 2338 patients (thoracotomy in 14 patients, pericardial 
drainage in 11 patients, transfusions in 4 pts. and 1 death) 20,21.
            Table 1. Results and complications of different extraction techniques.
        The use of femoral workstation was accompanied by 2 deaths and transient limb ischaemia 
in 1 patient  28. In the 149 patients of the European laser registry, complications included 
ventricular perforation in one patient; two other perforations were related to the reimplantation 
of leads and required surgery 29. There were no fatal complications. In the United States laser 
registry major complications occurred in 1.9 % of patients, mainly tamponade and haemothorax 
resulting in the demise of 12 patients (0.8%) 30. With electrosurgical sheaths, the first results of 
the Excl trial in 166 patients reported tamponade in 3 patients, haemothorax and AV fistula both 
in   1   patient.                                                                                            
            A direct comparison of complications between techniques is only available from the 
Plexus trial 23. Tamponade or hemothorax occurred only1 in 3 patients randomized to the laser 
group, one of whom died. Two patients in the laser group and 1 patient in the non-laser had 
venous thrombotic complications.                                                                               
            It is remarkable that the complication rates between endovascular extraction techniques 
are   comparable.   As   all   different   extraction   techniques   except   direct   traction   rely   on 
countertraction it is not surprising that tamponade resulting from perforation after dislocation of 
the lead tip is common to all these techniques. A second common predilection site for 
perforation is the lower superior vena cava. As the vessel wall is sometimes part of the fibrous 
envelope surrounding the leads, it can be exposed to the mechanical, laser or radiofrequency 
energy of the sheaths. Electrosurgical sheaths have the possibility of directional application of 
energy which should avoid the risk of damage to the vessel wall but this has yet to be proven. A 
femoral approach has an advantage in this respect as the proximal isodiametric part of the lead is 
most often simply pulled down through the binding sites avoiding applying sheaths in the vena 
cava   superior.                                                                                
            The risk of complications has been associated with physician's experience, number of 
leads extracted and female sex  20,21,30. Although implant duration was not linked with 
complications in any of the cited papers, major complications reported for extraction of Accufix 
leads (Telectronics Pacing Systems Inc. Englewood, Co, USA) increased from 2 % at one-year 
implant duration to 8.3 % with an implant duration of more than 5 years as reported by the 
Accufix Resarch Institute (data available on www.accufix.com ).                               
Conclusion.
            In practice, probably no technique is sufficient by itself to address all lead extractions. 
The necessity to use tools to extract leads largely depends on the time from implant. Within six 
months from implant it is rare that traction alone will not suffice. However, from that time on 
extraction tools are necessary in an increasing number of procedures 32.                                 
        Powered sheaths, laser or electrosurgical, provide the best chance of extracting the entire 
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lead, but have a risk of laceration of the veins along the proximal part of the lead. The most 
versatile technique is probably a femoral workstation and retriever system. It is the only 
technique suited to remove severed and indwelling leads and is very useful as back-up after a 
failed or stalled superior venous approach  22.                                                                     
            Although the complication rate of these extraction techniques seems low, their nature is 
life-threatening and hence extraction is only acceptable for indications that are vital or have a 
serious morbidity. Ergo, these procedures should be limited to the operation room with adequate 
cardio-surgical stand-by. The risk of emergency surgery itself is important to consider in 
advance. In some cases elective surgery is a preferable when risks of endocardial extraction are 
too high, even in the course of a procedure. There will always be a trade-off between 
perseverance to obtain successful extraction and complication rate.                              
            All considerations mentioned result that in our opinion only infected pacing systems 
qualify for primary lead extraction  33. In high-risk patients or in the absence of systemic 
infection alternative, albeit less efficient, treatments may be tried before lead extraction is 
performed. In case of non-functional or superfluous leads there is no proof that abandoning leads 
has a risk that justifies lead extraction 10,34. It is only defendable to extract non-functional leads 
that have a high chance of success without complications: an implant time less than one year, 
younger patients and no serious comorbidity.                                                               
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